| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.042 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.041 | 0.9 |